Sharekhan

Sudeep Pharma Ltd

Mon 1/12/2025,15:59:54 | NSE : SUDEEPPHRM

₹ 728.20-45.95 (-5.94%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 782.00

Previous Close

₹ 774.15

Volume

9937457

Mkt Cap ( Rs. Cr)

₹8224.92

High

₹ 786.90

Low

₹ 715.75

52 Week High

₹ 795.00

52 Week Low

₹ 725.00

Book Value Per Share

₹ 60.19

Dividend Yield

0.00

Face Value

₹ 1.00

What’s Your Call?

Collective community sentiment on Sudeep Pharma Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

728.20

10960

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

10960

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Sudeep Pharma Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Sudeep Pharma has submitted to BSE the Shareholding Pattern for the Period Ended November 27, 2025

    28 Nov 2025, 3:50PM As of November 2025, 76.16% is owned by Indian Promoters and 23.85% by Public. <p align=justify> Institutional holds 16.30% (Insurance Companies 0.40%
  • Sudeep Pharma - Trading Window

    28 Nov 2025, 1:45PM Sudeep Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 20
  • Sudeep Pharma Ltd. debuts with 23.76% premium at Rs 733.95

    28 Nov 2025, 9:50AM Sudeep Pharma Ltd. makes a strong debut on the bourses with scrip got listed at Rs 733.95 on the Bombay Stock Exchange, a 23.76 per cent premium to it
  • Sudeep Pharma announces launch of initial public offering

    18 Nov 2025, 2:40PM Sudeep Pharma Ltd. has announced public offering of 15092749 shares at a price of Rs 1.00 each for Cash at a Premium of Rs 592.00 per share. The gross

Key fundamentals

Evaluate the intrinsic value of Sudeep Pharma Ltd stock 

Name March-25 March-24
Assets 548.6406 392.6459
Liabilities 548.6406 392.6459
Equity 9.7228 1.4091
Gross Profit 131.9581 132.2239
Net Profit 95.7477 98.0786
Cash From Operating Activities 59.1509 59.0487
NPM(%) 26.84 28.53
Revenue 356.7318 343.759
Expenses 224.7737 211.5351
ROE(%) 14.08 14.42

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Sudeep Pharma Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 784.10 -1.11 0.00 0.00 301.39 0.64
Lotus Eye Hospital and Institute Ltd 105.11 -0.51 328.47 0.00 3.55 0.00
Vaishali Pharma Ltd 8.77 -0.23 0.00 0.00 3.13 0.00
Astec Lifesciences Ltd 819.70 -2.17 0.00 0.00 -604.77 0.00

Company Info

Our Company was incorporated as `Sudeep Pharma Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated December 21, 1989, issued by the Registrar of Companies, Gujarat at Ahmedabad. Thereafter, our Company was converted into a public limited company and the name of our Company was accordingly changed to `Sudeep Pharma Limited' pursuant to fresh certificate of incorporation dated April 5, 1995, issued by the Assistant Registrar of Companies, Gujarat at Dadra & Nagar Haveli. Our Company was subsequently converted back to a private limited company under the Companies Act, 2013 vide a fresh certificate of incorporation dated October 1, 2014 issued by the Assistant Registrar of Companies, Gujarat at Ahmedabad, and the name of our Company was accordingly changed from `Sudeep Pharma Limited' to `Sudeep Pharma Private Limited'. Further, pursuant to the special resolution passed by our shareholders dated August 17, 2024 and the fresh certificate of incorporation dated October 21, 2024 issued by the Registrar of Companies, Central Processing Centre, our Company was converted into a public limited company and consequently, the name of our Company was changed to `Sudeep Pharma Limited'.Major Events and Milestones:1989- Incorporation of our Company2017- Our Company obtained USFDA certification for mineral based ingredients2020- Incorporation of our Subsidiary, Sudeep Pharma USA Inc.2021- Incorporation of our Subsidiary, Sudeep Nutrition Private Limited2022- Our Company obtained written confirmation certification for sale of calcium carbonate as an active pharmaceutical ingredient.2023- Incorporation of our Subsidiary, Sudeep Pharma B.V.2024- Incorporation of our Subsidiary, Sudeep Advanced Materials Private Limited- Our Subsidiary, Sudeep Nutrition Private Limited, introduced liposomal encapsulation of nutrients for enhanced absorption2025- Acquisition of our Step-down Subsidiary, Nutrition Supplies and Services (Ireland) Limited

Our Company was incorporated as `Sudeep Pharma Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated December 21, 1989, issued by the Registrar of Companies, Gujarat at Ahmedabad. Thereafter, our Company was converted into a public limited company and the name of our Company was accordingly changed to `Sudeep Pharma Limited' pursuant to fresh certificate of incorporation dated April 5, 1995, issued by the Assistant Registrar of Companies, Gujarat at Dadra & Nagar Haveli. Our Company was subsequently converted back to a private limited company under the Companies Act, 2013 vide a fresh certificate of incorporation dated October 1, 2014 issued by the Assistant Registrar of Companies, Gujarat at Ahmedabad, and the name of our Company was accordingly changed from `Sudeep Pharma Limited' to `Sudeep Pharma Private Limited'. Further, pursuant to the special resolution passed by our shareholders dated August 17, 2024 and the fresh certificate of incorporation dated October 21, 2024 issued by the Registrar of Companies, Central Processing Centre, our Company was converted into a public limited company and consequently, the name of our Company was changed to `Sudeep Pharma Limited'.Major Events and Milestones:1989- Incorporation of our Company2017- Our Company obtained USFDA certification for mineral based ingredients2020- Incorporation of our Subsidiary, Sudeep Pharma USA Inc.2021- Incorporation of our Subsidiary, Sudeep Nutrition Private Limited2022- Our Company obtained written confirmation certification for sale of calcium carbonate as an active pharmaceutical ingredient.2023- Incorporation of our Subsidiary, Sudeep Pharma B.V.2024- Incorporation of our Subsidiary, Sudeep Advanced Materials Private Limited- Our Subsidiary, Sudeep Nutrition Private Limited, introduced liposomal encapsulation of nutrients for enhanced absorption2025- Acquisition of our Step-down Subsidiary, Nutrition Supplies and Services (Ireland) Limited

Read More

Parent Organisation

Sudeep Pharma Ltd.

Founded

21/12/1989

Managing Director

Mr.Sujit Jaysukh Bhayani

NSE Symbol

SUDEEPPHRMEQ

FAQ

The current price of Sudeep Pharma Ltd is ₹ 728.20.

The 52-week high for Sudeep Pharma Ltd is ₹ 786.90 and the 52-week low is ₹ 715.75.

The market capitalization of Sudeep Pharma Ltd is currently ₹ 8224.92. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Sudeep Pharma Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Sudeep Pharma Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Sudeep Pharma Ltd shares.

The CEO of Sudeep Pharma Ltd is Mr.Sujit Jaysukh Bhayani, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT